Serum Institute Sends Out First Vaccines As India Readies For Covid Shots


    Serum Institute Sends Out First Vaccines As India Readies For Covid Shots

    3 temperature-controlled trucks presented the vaccines from Serum Institute’s Pune facility.

    New Delhi:

    The very first consignment containing vials of Covishield vaccines left Serum Institute of India for Pune airport early today, 4 days ahead of the nationwide inoculation drive versus COVID-19

    Amidst tight security, 3 temperature-controlled trucks rolled out of the Serum Institute gates soon before 5 am and left for Pune airport, from where the vaccines will be flown throughout India. The trucks carried 478 boxes of the vaccines, each box weighing 32 kg, news firm PTI reported quoting an unnamed authorities. A “puja” was performed prior to the cars left the center.

    From the airport, the vaccines will be dispatched to 13 places across the nation. ” The first flight will leave for Delhi from Pune airport,” Sandip Bhosale, SB Logistics, the logistics group which is dealing with air transportation of Covishield vaccine from Pune International Airport was priced quote as stating by news company ANI.

    The vaccines will be flown from Pune in eight industrial flights, including 2 cargo flights, according to PTI. The first cargo flight will cover Hyderabad, Vijayawada, and Bhubaneswar and the second freight flight will go to Kolkata and Guwahati, PTI reported pricing quote a source.

    The consignment for Mumbai will leave by road.

    The federal government prepares to buy a total of 5.60 crore doses of Serum Institute’s Covishield vaccine by April 2021, at 200 per dose. While 1.10 crore dosages of Covishield were purchased on Monday, there is a “commitment” to buy another 4.50 crore doses by April 2021.


    The Hindustan Lifecare Limited or HLL, a Central enterprise, is the company which will purchase the vaccines from both Serum Institute of India and Bharat Biotech.

    2 vaccines– the Covishield developed by the Oxford University and pharma major AstraZeneca and Bharat Biotech’s Covaxin– received emergency situation usage approval from the Drug Controller of India earlier this month. Both are two-dose vaccines, which will need to be administered at a 28- day space.

    The rollout of the vaccines has actually been scheduled for January16 The federal government has said that 30 crore individuals – starting with health employees and frontline workers like the cops, civil defence personnel and sanitation employees – will be administered the vaccine in the very first phase.

    After them, the other vulnerable group, individuals who are over the age of 50 years and those who struggle with co-morbidities including diabetes and high blood pressure, will also be administered the vaccine.

    With inputs from firms

    ( the headline, this story has actually not been published by Essential India News staff and is published from a syndicated feed.).


    Please enter your comment!
    Please enter your name here